A new drug was approved to treat deadly lung conditions, for the first time in more than a decade

(MEDPAGE TODAY) – The US Food and Drug Administration (FDA) agreed to Nirandomilast (JASCAID) tablets for anonymous pulmonary fibrosis (IPF), the first new product of the progressive lung condition in more than a decade, the agency announced on Tuesday. The basic support for preference …